Systemic immunostimulation after retinal laser treatment in retinitis pigmentosa.
Systemic immunostimulation followed an experimental treatment trial of scatter argon laser photocoagulation directed to the retina of one eye of 10 patients with heredo-degenerative retinitis pigmentosa (RP). Significantly increased RP lymphocyte CD25, CD26, and CD4/CD26 activation epitope expressions over prelaser values and controls were found with a normalization of soluble interleukin-2 receptor secretion after laser treatment. Serum interferon-gamma was low both pre- and postlaser. Interestingly, when a panel of viral antibodies was tested, only those to rubella virus were elevated in the early postlaser period. The character of RP immunostimulation after laser-induced inflammation could be consistent with an antigenic stimulus from laser-released retinal proteins which might be of autoimmune or latent infectious origin. Enhanced immune responses may be a common but unrecognized sequellae of retinal laser.
Williams
L L
LL
Department of Ophthalmology, Ohio State University College of Medicine, Columbus.
Shannon
B T
BT
Chambers
R B
RB
Leguire
L E
LE
Davidorf
F H
FH
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000378:metabolism; D000917:Antibody Formation; D000943:Antigens, Differentiation / Q000378:metabolism; D005434:Flow Cytometry; D006801:Humans; D007111:Immunity, Cellular; D007371:Interferon-gamma / Q000378:metabolism; D007834:Lasers; D007958:Leukocyte Count; D008028:Light Coagulation; D008875:Middle Aged; D015375:Receptors, Interleukin-2 / Q000737:chemistry / Q000378:metabolism; D012174:Retinitis Pigmentosa / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D012995:Solubility
D000914:Antibodies, Viral; D000943:Antigens, Differentiation; D015375:Receptors, Interleukin-2; D007371:Interferon-gamma